Rapid tryptophan depletion reverses phenelzine‐induced suppression of REM sleep
Open Access
- 21 February 2003
- journal article
- clinical trial
- Published by Wiley in Journal of Sleep Research
- Vol. 12 (1), 13-18
- https://doi.org/10.1046/j.1365-2869.2003.00336.x
Abstract
Treatment with the monoamine oxidase inhibitor phenelzine completely suppressed rapid eye movement (REM) sleep in five depressed patients. Hypothesizing that increased serotonergic neurotransmission eliminated REM sleep, we administered a tryptophan‐free amino acid drink (TFD) known to reduce plasma tryptophan and brain levels of serotonin. The TFD reversed the REM sleep suppression, while the control drink (TFD plus tryptophan) had virtually no effect on sleep. Neither TFD nor control drink affected mood, total sleep time, sleep efficiency or the all‐night electroencephalogram power spectra in non‐rapid eye movement (NREM) sleep. We report the first non‐disruptive, double‐blind method for studying human subjects overnight with and without REM sleep. It opens up a novel strategy for investigating the functions of REM sleep, and the roles of serotonin and REM sleep in the regulation of NREM sleep and mood.Keywords
This publication has 29 references indexed in Scilit:
- Effects of Rapid Tryptophan Depletion on Sleep Electroencephalogram and Mood in Subjects with Partially Remitted Depression on BupropionNeuropsychopharmacology, 2002
- Predictors of Mood Response to Acute Tryptophan Depletion A ReanalysisNeuropsychopharmacology, 2002
- Different Effects of Phenelzine Treatment on EEG Topography in Waking and Sleep in Depressed PatientsNeuropsychopharmacology, 2002
- The REM Sleep-Memory Consolidation HypothesisScience, 2001
- Effect of Chronic Phenelzine Treatment on REM Sleep Report of Three PatientsNeuropsychopharmacology, 2001
- REM sleep — by default?Neuroscience & Biobehavioral Reviews, 2000
- Impact of Experimentally Induced Serotonin Deficiency by Tryptophan Depletion on Sleep EEG in Healthy SubjectsNeuropsychopharmacology, 1998
- The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockadeNeuroscience Letters, 1996
- The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in HumansPharmacopsychiatry, 1996
- Dependence on REM Sleep of Overnight Improvement of a Perceptual SkillScience, 1994